Filing Details

Accession Number:
0001209191-21-006365
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-29 21:00:09
Reporting Period:
2021-01-28
Accepted Time:
2021-01-29 21:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1812364 Relay Therapeutics Inc. RLAY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636994 Brian Adams C/O Relay Therapeutics, Inc.
399 Binney Street, 2Nd Floor
Cambridge MA 02139
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-28 5,000 $4.12 15,000 No 4 M Direct
Common Stock Disposition 2021-01-28 5,000 $55.05 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-28 5,000 $0.00 5,000 $4.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
166,786 2028-03-22 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $55.00 to $55.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  2. Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.